Naprosyn 500 Mg Tablet (Naproxen) – Non-Selective NSAID Anti-Inflammatory Therapy

Naprosyn 500 Mg Tablet (Naproxen) is an oral nonsteroidal anti-inflammatory drug (NSAID) indicated for the management of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute gouty arthritis, tendonitis, bursitis, and acute musculoskeletal pain. By reversibly inhibiting both cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, it suppresses peripheral prostaglandin biosynthesis, offering sustained analgesic, anti-inflammatory, and antipyretic relief.

What Is Naprosyn 500 Mg?

Naprosyn 500 Mg is an oral prescription formulation containing naproxen, a propionic acid derivative related to the arylacetic acid group of nonsteroidal anti-inflammatory agents. It is one of the most widely evaluated classic NSAIDs, providing sustained relief from joint inflammation, morning stiffness, and chronic structural pain.

The 500 Mg tablet is a primary therapeutic strength used in adult rheumatology and orthopedic practice. Naproxen possesses an extended plasma elimination half-life of approximately 12 to 17 hours, permitting a convenient twice-daily dosing regimen that maintains steady systemic anti-inflammatory levels throughout both day and night.

As with all nonsteroidal anti-inflammatory medications, clinical guidelines recommend using Naprosyn at the lowest effective dose for the shortest duration necessary to meet individual patient treatment goals.
([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bff5df5-d856-4237-b6a8-ae445b454844))

How Does Naprosyn 500 Mg Work?

Naproxen exerts its analgesic, antipyretic, and anti-inflammatory properties by reversibly inhibiting the cyclooxygenase (COX) enzyme system responsible for converting arachidonic acid into prostaglandins and thromboxanes:

• Dual COX-1 and COX-2 Blockade: It inhibits inducible COX-2, which is responsible for producing inflammatory prostaglandins (such as PGE2) that sensitize peripheral pain nociceptors and induce vasodilation, swelling, and fever at injury sites.
• Concurrent COX-1 Inhibition: It simultaneously inhibits constitutive COX-1 enzymes present in platelets and the gastrointestinal mucosa. While this contributes to reduced platelet thromboxane A2 production and mild antiplatelet effects, it also lowers cytoprotective mucosal prostaglandins.
• Joint & Synovial Penetration: Naproxen penetrates readily into synovial fluid, achieving therapeutic intra-articular concentrations that reduce joint effusion, cartilage inflammation, and stiffness.

Because naproxen non-selectively inhibits both isoforms, it provides potent anti-inflammatory action while requiring clinical attention to gastrointestinal mucosal defense.

What Is Naprosyn 500 Mg Used For?

Naprosyn 500 Mg is approved for the treatment of various acute and chronic inflammatory conditions:

• Osteoarthritis (OA): Relief of joint pain, tenderness, swelling, and limited mobility in weight-bearing and peripheral joints.
• Rheumatoid Arthritis (RA): Long-term management of systemic synovitis, joint tenderness, and morning stiffness in adults.
• Ankylosing Spondylitis (AS): Management of chronic inflammatory spinal stiffness, sacroiliac tenderness, and rest pain.
• Acute Gout Attacks: Rapid resolution of acute gouty flare-ups, joint heat, and periarticular edema.
• Acute Musculoskeletal & Tendon Disorders: Relief of severe tendonitis, bursitis, sprains, and acute soft tissue injuries.
• Primary Dysmenorrhea: Relief of menstrual cramps caused by elevated uterine prostaglandin synthesis.

Naprosyn is not indicated for treating minor aches and pains where short-acting over-the-counter analgesics or physical therapy measures are sufficient.
([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bff5df5-d856-4237-b6a8-ae445b454844))

Targeted COX-2 Anti-Inflammatory Therapy

For patients at elevated risk of gastrointestinal irritation or those requiring selective anti-inflammatory options that spare constitutive COX-1 mucosal defenses, explore our clinical profile on Celebrex:

Celebrex 200 mg Capsule

Naprosyn 500 Mg Dosage and Administration

Dosage schedules depend on the underlying condition and should be individually adjusted based on clinical response:

• Rheumatoid Arthritis, Osteoarthritis, & Ankylosing Spondylitis: The usual starting dose is 500 Mg orally twice daily (morning and evening) or 250 Mg twice daily. For acute flares requiring enhanced control, short-term doses up to 1500 Mg/day may be prescribed under medical supervision.
• Acute Gouty Arthritis: Recommended starting dose is 750 Mg initially, followed by 250 Mg every 8 hours until the acute gout attack subsides.
• Analgesia, Dysmenorrhea, Tendonitis & Bursitis: Initial dose of 500 Mg, followed by 250 Mg every 6 to 8 hours as needed. Total initial daily dose should not exceed 1250 Mg, and subsequent daily doses should not exceed 1000 Mg.

Tablets should be swallowed whole with a full glass of water. Ingesting Naprosyn with food, milk, or an antacid may help reduce mild stomach discomfort.
([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bff5df5-d856-4237-b6a8-ae445b454844))

Naprosyn 500 Mg (Naproxen) vs Celebrex 200 Mg (Celecoxib)

Comparing non-selective NSAIDs with selective COX-2 inhibitors highlights key differences in enzymatic selectivity, dosing, and safety considerations:

Naprosyn provides balanced, long-acting non-selective anti-inflammatory control, while Celebrex is favored for individuals requiring anti-inflammatory efficacy with lower upper gastrointestinal irritation risk.

Who Should Not Take Naprosyn 500 Mg?

Naprosyn is contraindicated in patients with the following clinical risk factors:

• Known hypersensitivity to naproxen or any inactive ingredients in the tablet
• History of asthma, urticaria, or allergic-type reactions following aspirin or other NSAIDs (aspirin-sensitive asthma triad)
• Immediate perioperative management in patients undergoing coronary artery bypass graft (CABG) surgery
• Active peptic ulceration, active gastrointestinal bleeding, or history of recurrent ulcer perforation
• Severe, uncompensated renal impairment ($\text{creatinine clearance} < 30\text{ mL/min}$)
• Severe congestive heart failure (NYHA Class II–IV) or uncontrolled severe hypertension
• Pregnancy at 30 weeks of gestation and later (due to risk of premature closure of the fetal ductus arteriosus and oligohydramnios)

Elderly patients and individuals with a history of cardiovascular disease require careful clinical screening before starting therapy.
([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bff5df5-d856-4237-b6a8-ae445b454844))

Possible Side Effects of Naprosyn 500 Mg

Like all systemic NSAIDs, Naprosyn can cause adverse reactions across several organ systems:

• Gastrointestinal: Dyspepsia, heartburn, abdominal pain, nausea, constipation, diarrhea, and stomatitis.
• Central Nervous System: Headache, dizziness, lightheadedness, somnolence, and tinnitus (ringing in the ears).
• Cardiovascular / Renal: Peripheral edema, fluid retention, blood pressure elevation, and changes in renal function parameters.
• Cutaneous: Pruritus, skin eruptions, ecchymoses, and rare severe reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis).

Seek emergency medical care immediately if you notice signs of gastrointestinal bleeding (black, tarry stools; vomiting blood) or cardiovascular events (chest tightness, shortness of breath, sudden weakness, slurred speech).
([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bff5df5-d856-4237-b6a8-ae445b454844))

Naprosyn 500 Mg Drug Interactions

Inform your physician and pharmacist of all prescription and over-the-counter medications you are taking:

Anticoagulants & Antiplatelets (Warfarin, Heparin, DOACs, Aspirin): Concomitant use significantly multiplies the risk of severe gastrointestinal bleeding. Naproxen reversibly inhibits platelet function; co-administration with warfarin requires regular prothrombin time/INR monitoring.

Antihypertensives (ACE Inhibitors, ARBs, Beta-blockers, Diuretics): NSAIDs may blunt the blood pressure-lowering efficacy of antihypertensive agents and increase the risk of acute kidney deterioration, especially in dehydrated or elderly individuals.

Lithium & Methotrexate: Naproxen reduces renal clearance of lithium and methotrexate, potentially elevating serum concentrations toward dangerous toxic thresholds.

Other NSAIDs: Combining naproxen with ibuprofen, diclofenac, or aspirin provides no additional therapeutic benefit and substantially increases gastrointestinal toxicity.
([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bff5df5-d856-4237-b6a8-ae445b454844))

Renal, Hepatic, and Fluid Retention Precautions

Renal prostaglandins play a vital compensatory role in preserving renal perfusion in patients with compromised circulating blood volume or renal disease. By blocking prostaglandin synthesis, naproxen can precipitate overt renal decompensation or acute interstitial nephritis.

Naprosyn is cleared predominantly via hepatic metabolism (glucuronide conjugation) and excreted by the kidneys (>95%). In patients with moderate hepatic disease or elderly patients with decreased unbound drug clearance, careful dose titration and periodic monitoring of serum creatinine, eGFR, and transaminases (ALT/AST) are clinically advised.
([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bff5df5-d856-4237-b6a8-ae445b454844))

Gastroprotection and Duration of Therapy

Because naproxen inhibits protective COX-1 mucosal prostaglandins, prolonged therapy increases the cumulative risk of gastric and duodenal erosions.

For patients requiring continuous, long-term therapy who present with risk factors for ulceration (such as age > 65 years, prior ulcer history, or concurrent corticosteroid use), clinicians frequently co-prescribe a gastroprotective agent, such as a proton pump inhibitor (PPI) or misoprostol, to preserve mucosal integrity.
([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bff5df5-d856-4237-b6a8-ae445b454844))

Official Medical Reference

For complete official prescribing information, clinical pharmacology monographs, black-box safety warnings, and approved indications for Naprosyn tablets, refer to the DailyMed reference database:

DailyMed – Naprosyn (Naproxen Tablets) Prescribing Information

Frequently Asked Questions About Naprosyn 500 Mg

Medical Disclaimer

This product summary is provided strictly for educational and informational purposes. Naprosyn 500 Mg (naproxen) is a prescription nonsteroidal anti-inflammatory medication that must be initiated, dosed, and managed under the supervision of a licensed healthcare practitioner. Clinical suitability depends on individual cardiovascular health, gastrointestinal ulcer history, kidney and liver function, and concurrent medications. This information does not replace professional medical advice, clinical diagnosis, or personalized treatment plans.